Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
LSI is continuing this momentum from LSI USA '22 going forward to our next event, LSI Europe '22. We are excited to bring more brilliant minds together in a new destination.
Accelerating surgical capability for life science businesses via precision VR simulation.
“We need more leaders today who have courage.” - Dale Jones, Former CEO & Current Senior Executive Advisor, Diversified Search Group.
A secure, complete software solution which expands surgical collaboration enabling surgeons to share expertise using augmented reality tools before, during and after surgery.
David Weild IV, is Founder, Chairman, and CEO of Weild & Co and former Vice Chairman of NASDAQ. He is recognized as the “father” of the JOBS Act and regarded as one the world’s top experts on capital markets and capital formation.
Facible Biodiagnostics is leading the diagnostic testing revolution through our mission to provide hospital-grade diagnostic tests to everyone, everywhere.
HealthySole is the pioneer and technology leader in reducing the pathogen load in settings where pristine environments are required: hospitals, compounding pharmacies, pharmaceutical R&D and manufacturing, food handling, and even EMS and law enforcement.
We are thrilled with the success of this year’s LSI USA '22 Emerging Medtech Summit. Thank you to all our partners and sponsors for making this one of the best years yet.
Developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.
Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's.
The IntelliSense Drill is an innovative handheld robotic technology which can change the standard of care in orthopedic procedures.
The annual LSI Emerging Medtech Summit took place March 15-18, 2022 in Dana Point California. This event is now recognized as the top medical device investor meeting in the world.
Noninvasive bio-therapeutic device for pain management.
Leveraging photonics to create a platform for small, safe and long-lasting neurostimulators.
Introduced through the nose, the Phagenyx catheter delivers electrical stimulation to the throat to treat dysphagia (difficulty swallowing).
FDA cleared non-invasive medical device that objectively assesses head injured patients for both brain bleeds & concussions at point of care.
New York Huaqi Bioengineering is developing products to preserve and enhance the health and functionality of donated human organs.
Wearable device for vein identification and enhancement for the ESRD patient.
OtoSet® is the first automated and FDA Cleared ear cleaning device for clinical use, which will be available to healthcare professionals soon.
Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
Innovative solutions to address unmet needs in GI endoscopy, cost-effectively improving clinical outcomes that benefit patients, providers and payers worldwide.
The company offers a growing range of simulators for teaching skills in critical care, medicine hysteroscopic and general surgery.
The Osso VR team has developed an orthopedic surgical training platform that allows surgeons to go "hands on" in an immersive, virtual training environment.
Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.
New View Surgical, Inc. is an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery.
Sense is developing a non-invasive, wearable device that continuously monitors brain activity primarily in the intensive care unit.
Sense Biodetection develops and commercializes an easy-to-use, affordable, disposable molecular diagnostic testing platform.
The company has developed iotaSoft, a miniature robotic system that is the size of a thumb. iotaSoft is capable of more accurately guiding the electrode of the cochlear implant through the ear, without damaging sensitive areas of the ear.
Vitara is developing a therapeutic platform to support infants born premature. It is the company's mission to protect preterm infants, improve their quality of life, and reduce comorbidities and mortality.